Literature DB >> 20496531

Epidemiology of gastrointestinal and liver tumors.

László Herszényi1, Zsolt Tulassay.   

Abstract

Colorectal cancer (CRC) is a worldwide problem, with an annual incidence of 1 million cases and an annual mortality of more than 500,000 cases. CRC is the second most common cause of cancer mortality. CRC comprises 9% of the global cancer burden and is the most frequent in North America, Australia, New Zealand and parts of Europe, being considered as a disease of the Western lifestyle. Despite a major decline in incidence and mortality, gastric cancer remains an important public health burden worldwide, especially in developing countries. Gastric cancer is still the fourth most common cancer and the second-third most common cause of cancer death. There is a 10-fold variation in incidence between populations at the highest and lowest risk. The incidence is particularly high in East Asia, Eastern Europe, and parts of Central and South America. Esophageal cancer is the eighth most common cancer worldwide and the sixth most common cause of cancer-related death. Regional incidence rates are highest in areas of Southern and Eastern Africa and China. A striking increase in the rates of esophageal adenocarcinoma, in contrast, stable or even decreased trends in squamous cell cancer have been observed. Pancreatic cancer ranks the fourth and fifth most common cancer in man and women, respectively, and has the lowest 5-year survival rate of any gastrointestinal tumors. Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third most common cause of cancer mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20496531

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  157 in total

1.  Silence of HIN-1 expression through methylation of its gene promoter in gastric cancer.

Authors:  Yan Gong; Ming-Zhou Guo; Zhi-Jia Ye; Xiu-Li Zhang; Yong-Liang Zhao; Yun-Sheng Yang
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Endoscopic imaging: How far are we from real-time histology?

Authors:  Richa Shukla; Wasif M Abidi; Rebecca Richards-Kortum; Sharmila Anandasabapathy
Journal:  World J Gastrointest Endosc       Date:  2011-10-16

Review 3.  Molecular subtypes in cancers of the gastrointestinal tract.

Authors:  Maarten F Bijlsma; Anguraj Sadanandam; Patrick Tan; Louis Vermeulen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-04-12       Impact factor: 46.802

4.  Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin.

Authors:  Kaoru Takabayashi; Kazuhiro Kashiwagi; Tetsuya Kawata; Toshiro Sato; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Hiromasa Takaishi; Toshifumi Hibi; Haruhiko Ogata; Naohisa Yahagi; Yuko Kitagawa; Naoyuki Shigematsu; Takanori Kanai
Journal:  Cancer Biol Ther       Date:  2013-10-22       Impact factor: 4.742

5.  Long non-coding RNA AB007962 is downregulated in gastric cancer and associated with poor prognosis.

Authors:  Jia-Jun Wang; Yu-Chong Yang; Yong-Xi Song; Peng Gao; Jing-Xu Sun; Xiao-Wan Chen; Bin Ma; Zhen-Ning Wang
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

Review 6.  Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis.

Authors:  Jian Song; Hong Su; Yang-Yang Zhou; Liang-Liang Guo
Journal:  Dig Dis Sci       Date:  2013-11-01       Impact factor: 3.199

7.  Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.

Authors:  Mehdi Manoochehri; Ashraf Karbasi; Mojgan Bandehpour; Bahram Kazemi
Journal:  Pathol Oncol Res       Date:  2013-10-14       Impact factor: 3.201

8.  Study of risk factors for gastric cancer by populational databases analysis.

Authors:  Fangio Ferrari; Marco Antonio Moura Reis
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

9.  Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway.

Authors:  Wei Ou; Jie Lv; Xiaohua Zou; Yin Yao; Jinli Wu; Jian Yang; Zhumei Wang; Yan Ma
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

Review 10.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.